Background illustration for clinical trials search

Paid Clinical Trials Overland Park

Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 722

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

for

Ovarian Cancer

Location: Fairway KS, Chicago IL, Phildelphia PA, Boston MA

Sponsor: Persevere Therapeutics Inc.

Sex: Female

Age: 18+

Code: NCT03854110

Phase1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for

Astrocytoma, IDH-Mutant, Grade 2,

Location: Fairway KS, Westwood KS, Kansas City KS,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase1, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Fairway KS, Westwood KS, Kansas City KS,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for

Extensive Stage Lung Small Cell Carcinoma,

Location: Fairway KS, Westwood KS, Overland Park KS,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined

for

Myelofibrosis，MF

Location: Fairway KS

Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT06414681

Early_phase1, Recruiting

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

for

Refractory Metastatic Colorectal Cancer

Location: Fairway KS, New Orleans LA, Salt Lake City UT, Tampa FL,

Sponsor: Delcath Systems Inc.

Sex: All

Age: 18+

Code: NCT06607458

Phase2, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for

Gastroesophageal Adenocarcinoma

Location: Fairway KS, North Shores MI, Washington D.C. DC,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase2, Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for

Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

Location: Fairway KS, Chicago IL, Dallas TX, Cincinnati OH,

Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase2, Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for

Delayed Graft Function, DGF, Kidney Transplant

Location: Fairway KS, Omaha NE, St Louis MO, Chicago IL,

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

for

Acute Myeloid Leukemia (AML)

Location: Fairway KS, Houston TX, Augusta GA, New York NY,

Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT02781883

Phase2, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for

cGVHD

Location: Fairway KS, Rochester MN, Maywood IL, Chicago IL,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

for

Bladder Cancer

Location: Fairway KS, Kansas City KS

Sponsor: Rahul Parikh

Sex: All

Age: 18+

Code: NCT03762161

Phase2, Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

for

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Location: Fairway KS, Westwood KS, Kansas City KS, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05172245

Phase1, Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for

Relapsed Multiple Myeloma, Refractory Multiple Myeloma

Location: Westwood KS, Grand Rapids MI, Detroit MI, Atlanta GA,

Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for

Advanced Breast Cancer

Location: Fairway KS, Springdale AR, Iowa City IA, Rochester MN,

Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

for

Advanced Solid Tumors With KRAS G12C Mutations,

Location: Fairway KS, Dyer IN, Houston TX, Detroit MI,

Sponsor: Frontier Medicines Corporation

Sex: All

Age: 18+

Code: NCT06244771

Phase1, Phase2, Recruiting

Study of APVO436 in Patients With AML or MDS

for

AML, MDS

Location: Westwood KS, Dallas TX, Denver CO, Columbus OH,

Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase1, Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for

Polymyositis, Dermatomyositis

Location: Fairway KS, Willowbrook IL, Allen TX, Milwaukee WI,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase3, Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for

Acute Myeloid Leukemia (AML)

Location: Fairway KS, Dallas TX, Cincinnati, OH, Denver CO,

Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT06634394

Phase1, Recruiting

MAGIC Ruxolitinib for aGVHD

for

Acute Graft-versus-host Disease,

Location: Fairway KS, Rochester MN, Nashville TN, Houston TX,

Sponsor: John Levine

Sex: All

Age: 18+

Code: NCT06936566

Phase2, Recruiting

Paid Clinical Trials Overland Park

Filter results

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined

Interested in new trials?

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Study of APVO436 in Patients With AML or MDS

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

MAGIC Ruxolitinib for aGVHD